Exact Sciences Corporation
Exact Sciences Corporation (EXAS) Insider Trading
Form 4 buy vs sell counts, ratio, and sentiment — switch this quarter or last 12 months; chart and transactions below.
SEC EDGAR · FMP · EXAS · as of Jun 8, 2026
Activity summary
Buy transactions
0
P-Purchase only
Sell transactions
9
12 Months
Buy/Sell ratio
0.00
Buy/Sell (by trades)
Overall sentiment
Exact Sciences Corporation insiders have been primarily selling shares over the past 12 Months. Selling activity is often driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment toward the company.
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · Buy = P-Purchase only · Sell = S-Sale only
As of Jun 8, 2026
EXAS insider buying and selling by quarter
EXAS insider selling · EXAS insider buying stocks · quarterly insider activity
Mobile shows last 4Q · Desktop shows full 8Q
▸ Source: SEC EDGAR · Form 3 & 4 · via Financial Modeling Prep · last 8 quarters
As of Jun 8, 2026
Active insiders
Most active in past 12 months · EXAS ceo insider trading
Showing all insiders · Click a card to filter the transactions table below
▸ Aggregated from reportingName · top 5 by trade count (12M) · no extra API
Recent insider transactions
EXAS executive sell shares · EXAS board member insider trading · EXAS insider trading SEC filing
Scroll horizontally to see all columns
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Mar 23, 2026 | Baranick Brian EVP, GM, Precision Oncology | Award | 33,321 | — | Form 4 |
| Mar 23, 2026 | Baranick Brian EVP, GM, Precision Oncology | Other | 795 | — | Form 4 |
| Mar 23, 2026 | Herriott James SVP, General Counsel & Sec | Other | 1,762 | $18 | Form 4 |
| Mar 23, 2026 | Bloomer Aaron EVP, Chief Financial Officer | Award | 89,911 | — | Form 4 |
| Mar 23, 2026 | Bloomer Aaron EVP, Chief Financial Officer | Other | 417 | — | Form 4 |
| Mar 23, 2026 | Condella Sarah EVP, Human Resources | Award | 60,389 | — | Form 4 |
| Mar 23, 2026 | Condella Sarah EVP, Human Resources | Other | 6,368 | — | Form 4 |
| Mar 23, 2026 | Conroy Kevin T President and CEO · Director | Award | 119,312 | — | Form 4 |
| Mar 23, 2026 | Conroy Kevin T President and CEO · Director | Other | 117,427 | — | Form 4 |
| Mar 23, 2026 | ORVILLE JACOB A EVP, GM, Screening | Award | 53,323 | — | Form 4 |
| Mar 23, 2026 | ORVILLE JACOB A EVP, GM, Screening | Other | 1,774 | — | Form 4 |
| Mar 23, 2026 | COWARD D SCOTT Director | Other | 52,164 | $522 | Form 4 |
| Mar 23, 2026 | COWARD D SCOTT Director | Other | 5,398 | — | Form 4 |
| Mar 23, 2026 | COWARD D SCOTT Director | Other | 4,694 | $47 | Form 4 |
| Mar 23, 2026 | Petrovic Shacey Director | Other | 16,406 | $164 | Form 4 |
| Mar 23, 2026 | Petrovic Shacey Director | Other | 5,398 | — | Form 4 |
| Mar 23, 2026 | Petrovic Shacey Director | Other | 7,095 | $71 | Form 4 |
| Mar 23, 2026 | Zanotti Katherine S Director | Other | 55,361 | $554 | Form 4 |
| Mar 23, 2026 | Zanotti Katherine S Director | Other | 5,398 | — | Form 4 |
| Mar 23, 2026 | Popovits Kimberly J Director | Other | 6,725 | $67 | Form 4 |
| Mar 23, 2026 | Popovits Kimberly J Director | Other | 9,656 | — | Form 4 |
| Mar 23, 2026 | Doyle James Edward Director | Other | 52,564 | $526 | Form 4 |
| Mar 23, 2026 | Doyle James Edward Director | Other | 5,398 | — | Form 4 |
| Mar 23, 2026 | Clancy Paul J Director | Other | 20,640 | $206 | Form 4 |
| Mar 23, 2026 | Clancy Paul J Director | Other | 5,398 | — | Form 4 |
Baranick Brian
EVP, GM, Precision Oncology
Date
Mar 23
Shares
33,321
Price
—
Value
—
Herriott James
SVP, General Counsel & Sec
Date
Mar 23
Shares
1,762
Price
$0.01
Value
$18
Bloomer Aaron
EVP, Chief Financial Officer
Date
Mar 23
Shares
89,911
Price
—
Value
—
Conroy Kevin T
President and CEO · Director
Date
Mar 23
Shares
119,312
Price
—
Value
—
Conroy Kevin T
President and CEO · Director
Date
Mar 23
Shares
117,427
Price
—
Value
—
⚡ = value ≥ $1M · Award/Option price shows — · formType=4 · securityName=Common Stock · url → sec.gov/Archives/edgar
▸ Source: SEC EDGAR · Form 4 filings · ⚡ = value ≥ $1M · Award/Option price shows —
About EXAS insider trading
EXAS insider trades
Exact Sciences Corporation (EXAS) insider trading data is sourced from SEC Form 4 filings submitted by corporate insiders, including ORVILLE JACOB A (EVP, GM, Screening), Baranick Brian (EVP, GM, Precision Oncology), Conroy Kevin T (President and CEO · Director). Over the past 12 months, 5 insiders have filed transactions with the SEC. EXAS insiders have been primarily selling, which may reflect pre-scheduled Rule 10b5-1 plan executions.
For Exact Sciences Corporation's institutional ownership breakdown and insider ownership percentage, see the Ownership tab → Ownership tab →
Frequently asked questions
EXAS insider trading · 5 questionsThe insiders of Exact Sciences Corporation (EXAS) include executives and directors such as ORVILLE JACOB A (EVP, GM, Screening), Baranick Brian (EVP, GM, Precision Oncology), Conroy Kevin T (President and CEO · Director), among others. Over the past 12 months, 5 insiders have filed Form 4 transactions with the SEC. Insider transactions are required to be reported within 2 business days of the trade date.
▸ Source: FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · acquisitionOrDisposition A=Buy, D=Sell · RSU vesting (M-Exempt) excluded from sentiment bar · As of Jun 8, 2026